United Kingdom-London: NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products
Details
| Contract Title: | United Kingdom-London: NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products |
| Published Date: | Sep 21, 2025 |
| Notice Type: | Notice (ContractNotice) |
| Value Banding: | High Value |
| Delivery Point: | United Kingdom |
Description:
NHS National Proprietary Pharmaceuticals – Low Molecular Weight Heparins and Fondaparinux Products – CM/PHR/22/5732 Period of Framework Agreement: 1 March 2026 to 29 February 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months....